UROwebinar: Adverse events and toxicity management of mPCa patients from an MDT perspective

(58:26)

UROwebinar: Handling adverse events after intravesical instillations in NMIBC

(59:49)

UROwebinar: Next generation imaging in renal cancer

(1:5:10)

UROwebinar: Infections, antimicrobial stewardship and PCa detection: TP vs TRUS prostate biopsy

(1:1:24)

UROwebinar: Bladder neoplasms: Will a morphological classification become obsolete?

(1:5:43)

UROwebinar: Ureteral stenosis and stones: The dog that chases its own tail

(1:11:16)

UROWebinar: Benign Prostatic Obstruction BPO: to prolong medical therapy or to move to MIST?

(1:8:22)

Urowebinar: Strategies in urology to tackle antibiotic resistance

(50:51)

UROwebinar: Renal, bladder and prostate cancer guidelines 2021: From guidelines to real world

(1:5:21)

Urowebinar: MRI and active surveillance in prostate cancer

(54:39)

UROwebinar: Management of nmCRPC: Putting current evidence into practice

(51:5)

UROwebinar: Follow up of patients with urolithiasis

(1:12:10)

UROwebinar - Learn from the experts

(1:5)

UROwebinar: Management of nmCRPC: Putting current evidence

(1:7:50)

UROwebinar: Update on the neuro urology guidelines

(1:6:58)

Urowebinar: Minimally Invasive Treatment for Male LUTS

(1:2:28)

UROwebinar: How to overcome individual challenges in contemporary BPO management

(1:20)

UROwebinar: Heat Free robotic treatment of Benign Prostatic Obstruction – from vision to reality

(58:27)

Urowebinar: Is immune therapy changing the way we think about early bladder cancer?

(39:23)